Catalyst Wire Dossier Catalyst Wire Dossier

Solnatide

solnatide · Apeptico Forschung und Entwicklung GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Solnatide, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS [Phase 2]

See pricing